Macrophage Inhibitory Factor (MIF) Gene Polymorphisms Are Associated with Disease Susceptibility and with Circulating MIF Levels in Active Non-segmental Vitiligo in Patients from Western Mexico

Overview

Journal Mol Genet Genomic Med

Specialty Genetics

Date 2020 Jul 25

PMID 32705792

Citations 9

Authors

Alejandra Garcia-Orozco

Itzel Alejandra Martinez-Magana

Annie Riera-Leal

Jose Francisco Munoz-Valle

Marco Alonso Martinez-Guzman

Ricardo Quinones-Venegas

Gabriela Athziri Sanchez-Zuno

Mary Fafutis-Morris

Affiliations

Soon will be listed here.

Abstract

Background: The macrophage migration inhibiting factor (MIF) is a protein that promotes the activation of immune cells and the production of other proinflammatory cytokines such as TNF-α, IL-1β, and IFN-γ, which have proposed to play an essential role in the pathogenesis of vitiligo. The study aimed to assess the association between MIF polymorphisms (-794 CATT and -173 G>C), MIF in situ expression, and MIF serum concentrations with susceptibility and disease activity in patients with non-segmental vitiligo (NSV) from western Mexico.

Methods: The study included 111 patients with NSV and 201 control subjects. Genotyping was performed by conventional PCR (-794 CATT ) and PCR-RFLP (-173 G>C) methods. MIF mRNA expression was quantified by real-time PCR and MIF serum concentrations were determined by ELISA kit. Histopathological samples were analyzed by automated immunohistochemistry.

Results: The MIF polymorphisms were associated with NSV susceptibility. Serum concentrations of MIF were higher in patients with active NSV and correlated negatively with the years of evolution. The depigmented skin from patients with active vitiligo showed a high expression of MIF.

Conclusion: MIF polymorphisms increase the risk of NSV in the western Mexican population. The serum concentrations of MIF and in situ expression are associated with active NSV.

Citing Articles

Prevalence and burden of vitiligo in Africa, the Middle East and Latin America.

Hammadi A, Silva de Castro C, Parmar N, Ubogui J, Hatatah N, Ahmed H Skin Health Dis. 2024; 4(1):e317.

PMID: 38312261 PMC: 10831562. DOI: 10.1002/ski2.317.

Erzhiwan Ameliorates Restraint Stress- and Monobenzone-Induced Depigmentation in Mice by Inhibiting Macrophage Migration Inhibitory Factor and 8-Hydroxy-2-Deoxyguanosine.

Tang N, Liu X, Lin X, Yang W, Li Q, Wang G Clin Cosmet Investig Dermatol. 2024; 17:147-158.

PMID: 38283796 PMC: 10812780. DOI: 10.2147/CCID.S420385.

Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis.

Lai N, Yu H, Huang H, Tseng H, Lu M Mediators Inflamm. 2023; 2023:2440377.

PMID: 37731844 PMC: 10509001. DOI: 10.1155/2023/2440377.

Association Among , and Gene Polymorphisms and Non-Segmental Vitiligo in a Chinese Han Population.

Wang D, Min S, Lin X, Jiang G Clin Cosmet Investig Dermatol. 2022; 15:1597-1609.

PMID: 35983127 PMC: 9380431. DOI: 10.2147/CCID.S369418.

Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris.

Hassan M, Abuhamdah S, Elsadek B, Abdelwahab A, Abd-Elhamid T, Fayed H Clin Cosmet Investig Dermatol. 2022; 15:1073-1085.

PMID: 35712358 PMC: 9196281. DOI: 10.2147/CCID.S363916.

References

van den Boorn J, Konijnenberg D, Dellemijn T, van der Veen J, Bos J, Melief C . Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol. 2009; 129(9):2220-32. DOI: 10.1038/jid.2009.32. View

Fallica J, Varela L, Johnston L, Kim B, Serebreni L, Wang L . Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis. Am J Respir Cell Mol Biol. 2015; 54(4):504-14. PMC: 4821049. DOI: 10.1165/rcmb.2014-0403OC. View

Sakaue S, Ishimaru S, Hizawa N, Ohtsuka Y, Tsujino I, Honda T . Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity. Int J Obes (Lond). 2005; 30(2):238-42. DOI: 10.1038/sj.ijo.0803148. View

Kuai S, Ou Q, You D, Shang Z, Wang J, Liu J . Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis. Infect Dis (Lond). 2015; 48(3):222-8. DOI: 10.3109/23744235.2015.1107188. View

Kim B, Pallua N, Bernhagen J, Bucala R . The macrophage migration inhibitory factor protein superfamily in obesity and wound repair. Exp Mol Med. 2015; 47:e161. PMC: 4454997. DOI: 10.1038/emm.2015.26. View

Rodrigues M, Ezzedine K, Hamzavi I, Pandya A, Harris J . New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017; 77(1):1-13. DOI: 10.1016/j.jaad.2016.10.048. View

Ezzedine K, Lim H, Suzuki T, Katayama I, Hamzavi I, Lan C . Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012; 25(3):E1-13. PMC: 3511780. DOI: 10.1111/j.1755-148X.2012.00997.x. View

Rashighi M, Harris J . Vitiligo Pathogenesis and Emerging Treatments. Dermatol Clin. 2017; 35(2):257-265. PMC: 5362109. DOI: 10.1016/j.det.2016.11.014. View

Sisti A, Sisti G, Oranges C . Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review. An Bras Dermatol. 2016; 91(2):187-95. PMC: 4861566. DOI: 10.1590/abd1806-4841.20164012. View

10.

Shimizu T, Ohkawara A, Nishihira J, Sakamoto W . Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization. FEBS Lett. 1996; 381(3):199-202. DOI: 10.1016/0014-5793(96)00120-2. View

11.

Otukesh H, Fereshtehnejad S, Hoseini R, Hekmat S, Chalian H, Chalian M . Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis. Pediatr Nephrol. 2008; 24(1):105-11. DOI: 10.1007/s00467-008-0969-9. View

12.

Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J . Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 2003; 4(7):487-91. DOI: 10.1038/sj.gene.6364014. View

13.

Speeckaert R, Speeckaert M, de Schepper S, van Geel N . Biomarkers of disease activity in vitiligo: A systematic review. Autoimmun Rev. 2017; 16(9):937-945. DOI: 10.1016/j.autrev.2017.07.005. View

14.

Ostergaard C, Benfield T . Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection. Crit Care. 2009; 13(3):R101. PMC: 2717473. DOI: 10.1186/cc7933. View

15.

Fallica J, Boyer L, Kim B, Serebreni L, Varela L, Hamdan O . Macrophage migration inhibitory factor is a novel determinant of cigarette smoke-induced lung damage. Am J Respir Cell Mol Biol. 2014; 51(1):94-103. PMC: 4091857. DOI: 10.1165/rcmb.2013-0371OC. View

16.

Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H . Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology. 2004; 146(3):1006-11. DOI: 10.1210/en.2004-0924. View

17.

Nishihira J, Sakaue S . Overview of Macrophage Migration Inhibitory Factor (MIF) as a Potential Biomarker Relevant to Adiposity. J Tradit Complement Med. 2014; 2(3):186-91. PMC: 3942894. DOI: 10.1016/s2225-4110(16)30098-0. View

18.

Makhija R, Kingsnorth A, Demaine A . Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. JOP. 2007; 8(3):289-95. View

19.

Awandare G, Martinson J, Were T, Ouma C, Davenport G, Ongecha J . MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J Infect Dis. 2009; 200(4):629-37. PMC: 3607439. DOI: 10.1086/600894. View

20.

Llamas-Covarrubias M, Valle Y, Navarro-Hernandez R, Guzman-Guzman I, Ramirez-Duenas M, Rangel-Villalobos H . Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course. Rheumatol Int. 2011; 32(8):2307-11. DOI: 10.1007/s00296-011-1951-6. View